Results 121 to 130 of about 17,265 (196)

Tumor Number and Model for End-Stage Liver Disease Score as Selection Criteria for Resection or Embolization of Intermediate-Stage Hepatocellular Carcinoma. [PDF]

Cancer Rep (Hoboken)
Yen YH, Yong CC, Liu YW, Li WF, Wang CC, Lin CY.   +5 more
europepmc   +1 more source

Efficacy and safety of CalliSpheres drug-eluting bead transarterial chemoembolization for unresectable gastrointestinal stromal tumor liver metastases after failure of targeted therapy: a multicenter retrospective study. [PDF]

Front Oncol
Liu S, Chen T, Yin S, Yu G, Wang Q, Li L, Zhao G, Zhang L, Zhuang B.   +8 more
europepmc   +1 more source

DEB-TACE Combined with Immunotherapy and Targeted Therapy for Advanced Hepatocellular Carcinoma with Scapular Metastasis: A Case Report. [PDF]

J Hepatocell Carcinoma
Zhang W, Kang D, Xu Q, Piao L.
europepmc   +1 more source

Efficacy and safety of transarterial chemoembolization plus donafenib with or without camrelizumab for unresectable hepatocellular carcinoma: a propensity score matching analysis. [PDF]

Front Immunol
Zhang Q, Lei Z, Qing H, Xie X.
europepmc   +1 more source

Reply to the Comment on the Article "Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor Based Combination Therapy for Unresectable Hepatocellular Carcinoma". [PDF]

Liver Cancer
Huang ZH, Huang JL, Lin LP, Yang DL, Ma L, Zhong JH, GUIDANCE Investigators.   +6 more
europepmc   +1 more source

Survival benefits of non-surgical triple therapy in hepatocellular carcinoma with inferior vena cava/right atrial tumor thrombus: A retrospective analysis from a multidisciplinary team. [PDF]

Oncol Lett
Tang P, Li J, Duan J, Wang X, Zhou J, Yang Y, Zeng Y.   +6 more
europepmc   +1 more source

Drug-eluting bead transarterial chemoembolization combined with immune checkpoint inhibitors is associated with improved progression-free survival in locally advanced or metastatic sarcoma: a retrospective propensity score-matched analysis. [PDF]

Ther Adv Med Oncol
Zhou C, Li H, Qian G, Yu W, Zheng S, Shen Z, Wang Y.   +6 more
europepmc   +1 more source

Effect of hepatic arterial dexamethasone administration on long-term survival among hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization. [PDF]

BMC Anesthesiol
Yan F, Wang Y, Huang Y, Xing W, Guo Y.
europepmc   +1 more source

Efficacy and safety of multiple treatments for small hepatocellular carcinoma: an updated systematic review and component network meta analysis. [PDF]

EClinicalMedicine
Sun P, Wu J, Cai D, Lv T, Jin Y, Tang H, Li F, Hu H.   +7 more
europepmc   +1 more source

Drug-eluting bead TACE improves the efficacy of HAIC combined with molecular-targeted therapy and anti-PD-1 immunotherapy in large hepatocellular carcinoma with inferior vena cava and/or right atrium tumor thrombus: a multicenter retrospective cohort study. [PDF]

BMC Cancer
Ni J, Sun H, Li C, Liu Y, Guo G, Zhou X, Zhou Z, Fan R, Hu H, Fang Z, Xu L.   +10 more
europepmc   +1 more source